Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi Su

Showing results (1111-1120 of 1,172) with videos related to

Pageof 118
Sort By:
Cancer Letters|November 17, 2016
Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trialsBo Yuan, Na Ye, Shan-Shan Song, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2022
Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's diseaseDavid Aguillon, Stephanie Langella, Yinghua Chen, et al.
Oncotarget|July 25, 2016
Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patientsKuo-Hsuan Hsu, Jeng-Sen Tseng, Chih-Liang Wang, et al.
Bjpsych Open|June 29, 2021
Protocol for a pharmacogenomic study on individualised antipsychotic drug treatment for patients with schizophreniaYi Su, Hao Yu, Zhiren Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 16, 2026
Brain regional susceptibility to tauopathy in individuals at risk for chronic traumatic encephalopathyTim L T Wiegand, Anna Rubinski, Leonard B Jung, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 15, 2020
Recommendations and guidelines for the treatment of Clostridioides difficile infection in TaiwanKuan-Sheng Wu, Ling-Shan Syue, Aristine Cheng, et al.
The Lancet. Neurology|May 30, 2020
Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort studyYakeel T Quiroz, Henrik Zetterberg, Eric M Reiman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 14, 2022
A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease TrialEric M Reiman, Jeremy J Pruzin, Silvia Rios-Romenets, et al.
Cancer|March 23, 2023
Poor pretransplantation minimal residual disease clearance as an independent prognostic risk factor for survival in myelodysplastic syndrome with excess blasts: A multicenter, retrospective cohort studyYing-Ying Ma, Ze-Liang Wei, Ya-Jing Xu, et al.
Oncotarget|December 8, 2016
Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distributionJin-Xue He, Meng Wang, Xia-Juan Huan, et al.
Pageof 118

Showing results (1111-1120 of 1,172) with videos related to

Sort By:
Pageof 118
Cancer Letters|November 17, 2016
Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trialsBo Yuan, Na Ye, Shan-Shan Song, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2022
Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's diseaseDavid Aguillon, Stephanie Langella, Yinghua Chen, et al.
Oncotarget|July 25, 2016
Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patientsKuo-Hsuan Hsu, Jeng-Sen Tseng, Chih-Liang Wang, et al.
Bjpsych Open|June 29, 2021
Protocol for a pharmacogenomic study on individualised antipsychotic drug treatment for patients with schizophreniaYi Su, Hao Yu, Zhiren Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 16, 2026
Brain regional susceptibility to tauopathy in individuals at risk for chronic traumatic encephalopathyTim L T Wiegand, Anna Rubinski, Leonard B Jung, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 15, 2020
Recommendations and guidelines for the treatment of Clostridioides difficile infection in TaiwanKuan-Sheng Wu, Ling-Shan Syue, Aristine Cheng, et al.
The Lancet. Neurology|May 30, 2020
Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort studyYakeel T Quiroz, Henrik Zetterberg, Eric M Reiman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 14, 2022
A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease TrialEric M Reiman, Jeremy J Pruzin, Silvia Rios-Romenets, et al.
Cancer|March 23, 2023
Poor pretransplantation minimal residual disease clearance as an independent prognostic risk factor for survival in myelodysplastic syndrome with excess blasts: A multicenter, retrospective cohort studyYing-Ying Ma, Ze-Liang Wei, Ya-Jing Xu, et al.
Oncotarget|December 8, 2016
Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distributionJin-Xue He, Meng Wang, Xia-Juan Huan, et al.
Pageof 118